文献速递小儿耳鼻咽喉咽喉与嗓音

儿童扁桃体切除术前布洛芬的安全性

Safety of preoperative ibuprofen in pediatric tonsillectomy.
PubMed 文献 · Laryngoscope · 2018-05-14

该个案对照研究纳入2013—2015年未用术前布洛芬与2016—2017年术前口服布洛芬7 mg/kg的儿童扁桃体/腺样体扁桃体切除病例,比较术中及术后出血。共217例,两组均无显著术中或早期术后出血,迟发出血率相似,提示术前布洛芬未增加出血风险。

要点

  • 术前口服布洛芬7 mg/kg未增加儿童扁桃体切除术中及早期术后出血。
  • 两组迟发出血率相似,安全性数据支持未来开展前瞻性随机研究。
  • 该研究未评估镇痛效果,不能据此推断术前布洛芬的止痛获益。

核心结论

  • 本系列中,术前接受布洛芬的儿童在扁桃体切除术中及术后早期未见出血增加。
  • 有利的安全性数据支持未来开展前瞻性随机研究,评估术前布洛芬减少儿童扁桃体切除术后疼痛与阿片需求的有效性。

研究设计与样本

  • 个体病例对照研究,比较2013年1月至2015年12月未接受术前布洛芬与2016年1月至2017年12月术前口服布洛芬7 mg/kg的扁桃体切除或腺样体扁桃体切除儿童。
  • 共217名儿童符合纳入标准,其中112例未接受术前布洛芬,105例接受术前布洛芬。
  • 非布洛芬组平均年龄8.7岁(范围1-18),布洛芬组平均年龄8.3岁(范围1-18)。
  • 证据等级3b,发表于Laryngoscope 2018;128:2415-2418。

主要发现

  • 非布洛芬组无一例发生显著术中或早期术后出血(95%CI 0-0.027)。
  • 布洛芬组无一例发生显著术中或早期术后出血(95%CI 0-0.029)。
  • 两组迟发出血率相似。

关键数值与推荐

  • 结局指标为术中出血>50 mL或需手术控制的早期术后出血,并记录迟发出血事件。
  • 术前布洛芬剂量为口服7 mg/kg。

临床怎么用

  • 对于需行扁桃体切除或腺样体扁桃体切除的儿童,术前口服布洛芬7 mg/kg在本系列中未显示增加术中及早期术后出血风险。
  • 因未研究镇痛效果,临床不能据此常规以术前布洛芬替代术后镇痛方案,仍需个体化评估。
  • 可向家长说明该剂量下本系列未见出血风险增加,但证据等级为3b。

局限性

  • 为个体病例对照研究,非随机设计,证据等级3b。
  • 未研究患者的疼痛控制情况。
  • 样本来自单中心两个时间段,可能存在时间相关混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Oral ibuprofen is believed to be safe and effective after pediatric adenotonsillectomy. There has been little study of its use as a preoperative analgesic. We attempt to document its safety in this setting. STUDY DESIGN: Individual case control study. METHODS: Children who underwent tonsillectomy or adenotonsillectomy from January 2013 to December 2015 did not receive preoperative ibuprofen. Those who underwent tonsillectomy or adenotonsillectomy from January 2016 to December 2017 received oral ibuprofen 7 mg/kg preoperatively. Pre- and postoperative records were reviewed. Intraoperative bleeding > 50 mL or early postoperative bleeding requiring surgical control were outcome measures. Delayed bleeding events were also recorded. RESULTS: A total of 217 children met inclusion criteria. Of those, 112 patients did not receive preoperative ibuprofen, and 105 patients did receive preoperative ibuprofen. Mean age was 8.7 years (range: 1-18) in the control/non-ibuprofen cohort and 8.3 years (range: 1-18) in the ibuprofen cohort. No child experienced significant intraoperative or early postoperative bleeding in the non-ibuprofen (95% confidence interval [CI] 0-0.027) or in the ibuprofen cohort (95% CI 0- 0.029). Delayed bleeding rates were similar in both groups. CONCLUSION: In this series, children treated with preoperative ibuprofen did not experience increased bleeding during or soon after tonsillectomy compared to controls. Pain control was not studied in these patients. These favorable safety data argue for a future prospective randomized study of preoperative ibuprofen's effectiveness in reducing pain and opioid requirement after pediatric tonsillectomy. LEVEL OF EVIDENCE: 3b. Laryngoscope, 128:2415-2418, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Michael A, Buchinsky FJ, Isaacson G, et al. Safety of preoperative ibuprofen in pediatric tonsillectomy. Laryngoscope. 2018. PMID: 29756342. doi:10.1002/lary.27241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。